SOURCE: MMRGlobal, Inc. LOS ANGELES, CA--(Marketwire - December 13, 2010) -  MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that Sunil Singhil has been named Executive Vice President and a member of the Executive Committee, succeeding Rich Teich, who will focus on the sales, marketing and installation support for MMRPro and MMRPatientView, ...

SOURCE: Cutting Edge Information Top Research Topics in 2010 Point Spotlight on Where Companies Will Be Taking Action Next Year and Beyond, Says Management Consulting Firm Cutting Edge Information RESEARCH TRIANGLE PARK, NC--(Marketwire - December 9, 2010) - As many companies put the finishing touches on their 2011 Action Plans, the ...

SOURCE: Radient Pharmaceuticals Corporation TUSTIN, CA--(Marketwire - December 7, 2010) -   Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) in partnership with Jaiva Technologies, today announced the formation of NuVax Therapeutics, Inc. ("NuVax") -- a wholly owned subsidiary of Radient Pharmaceuticals. The formation of NuVax Therapeutics is a strategic move on the ...

SOURCE: Medistem Inc. Internationally Renowned Drug Developers Join Adult Stem Cell Company SAN DIEGO, CA--(Marketwire - December 7, 2010) - Medistem Inc. (PINKSHEETS: MEDS) announced today the appointment of Dr. Vladimir Bogin as President and Chairman of the Board, Dr. Sergey Sablin as Vice President and Board Member, and Vladimir Zaharchook as ...

SOURCE: ASC X12 CHICAGO, IL--(Marketwire - December 2, 2010) - Based on mutual interest in the use of effective and productive electronic data interchange standards in the health care industry, the Healthcare Information and Management Systems (HIMSS) and the Accredited Standards Committee X12 (ASC X12) signed a Memorandum of Understanding ...

SOURCE: Proteonomix MOUNTAINSIDE, NJ--(Marketwire - December 2, 2010) - Proteonomix, Inc. (OTCBB: PROT) ("Proteonomix" or the "Company") announced today that it has updated its corporate website (http://www.proteonomix.com/) to reflect the dynamic growth and investment opportunity that exists today. Michael Cohen, CEO stated: "The ...

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 2, 2010) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCQB:APCSF) (the "Company") announces that new tests have shown that T36® Antiseptic Hand Sanitizer is completely effective against two types of new "superbugs" within 15 seconds. The testing was conducted ...

SOURCE: MMRGlobal, Inc. LOS ANGELES, CA--(Marketwire - November 30, 2010) - MMRGlobal, Inc. (OTCBB: MMRF) (MMR) today announced it has signed a settlement agreement with the Lymphoma Research Foundation (LRF), resolving its lawsuit with LRF and giving the Company exclusive control of certain data and tissue samples created during trials ...

SOURCE: Cutting Edge Information Patient Availability Is a Key Driving Force for Companies Conducting Clinical Studies in Emerging Markets, Finds Cutting Edge Information RESEARCH TRIANGLE PARK, NC--(Marketwire - November 22, 2010) - The population of Brazil, Russia, India and China, roughly three billion people, coupled with these countries' growing emphasis on ...

SOURCE: MacPractice, Inc. LINCOLN, NE--(Marketwire - October 26, 2010) -  MacPractice, the leading Apple developer of practice management and clinical software on Macs and iPhones for medical, dental and chiropractic offices, today announced the release of MacPractice iPad Interface with ePrescribe. The solution was designed with Apple's Web App development tools ...

SOURCE: Pharos Innovations NORTHFIELD, IL--(Marketwire - October 21, 2010) -  Randall E. Williams, MD, CEO and founder of Pharos Innovations, has been elected to chair the Government Affairs Committee of the Care Continuum Alliance, an organization focused on strategies to improve healthcare quality and outcomes and reduce preventable costs. As chair ...

SOURCE: Helix BioPharma Corp. After Treatment, 71.4% of the Women No Longer Had Potentially Pre-Cancerous Low-Grade CIN 1 or CIN 2 Cervical Lesions AURORA, ON--(Marketwire - October 21, 2010) -  Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of ...

SOURCE: AVI BioPharma, Inc. BOTHELL, WA--(Marketwire - October 20, 2010) -  AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced the presentation of data from the Company's Duchenne muscular dystrophy and influenza programs at the 6th Annual Meeting of the Oligonucleotide Therapeutics Society in Dana Point, Calif. ...

SOURCE: First China Pharmaceutical Group, Inc. HONG KONG--(Marketwire - October 19, 2010) -  First China Pharmaceutical Group, Inc. (OTCBB: FCPG) ("First China" or the "Company") is pleased to announce it has recently signed agreements to distribute medicinal and pharmaceutical products to three district hospitals in Yunnan Province, thereby dramatically increasing its ...

SOURCE: SpectraScience, Inc. SAN DIEGO, CA--(Marketwire - October 13, 2010) -  SpectraScience, Inc. (OTCBB: SCIE), a San Diego based medical device company, today announced that Jim Hitchin, the Company's current Chairman and CEO, resigned as Chairman effective October 8, 2010 and that the Board elected Mark McWilliams to assume the duties ...

SOURCE: Radient Pharmaceuticals Corporation TUSTIN, CA--(Marketwire - October 13, 2010) - Provista Life Sciences and Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced today the validation study results of a blood test for early detection of lung cancer and Provista's plans to broadly introduce this new test to market. ...

SOURCE: Vicor Technologies, Inc. BOCA RATON, FL--(Marketwire - October 12, 2010) -  David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that the Company completed the sale of $2.75 million principal amount, 10% convertible notes due in 2012 and warrants to purchase an aggregate of 6,111,000 shares of ...

SOURCE: The Amergence Group DENVER, CO and PHOENIX, AZ--(Marketwire - October 8, 2010) -  The Amergence Group (PINKSHEETS: AMNG), a company that focuses on developing, nurturing, and rapidly expanding selected emerging or "disruptive" companies across a wide range of industries and disciplines, announced today that it has completed the successful ...

SOURCE: Ewing Marion Kauffman Foundation Papers Range From Recommendations for Accelerating Drug Development to an Analysis of a New Health Care Reform Provision KANSAS CITY, MO--(Marketwire - October 4, 2010) -  The Ewing Marion Kauffman Foundation will release several studies over the next month on various aspects of health care. Topics range ...

SOURCE: Proteomics International Findings Announced at the Human Proteome Organisation's World Congress in Sydney, Australia PERTH, AUSTRALIA--(Marketwire - September 29, 2010) -  After three years of collaborative research involving patients from The Busselton Health Study, drug discovery company Proteomics International announced the identification and analytical validation of 13 protein biomarkers for ...